Tabassum, N., & Yasmin, H. (2024). Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: A pharmacovigilance study. Brac University.
Chicago Style aipamenaTabassum, Nadira, and Hasina Yasmin. Gender-specific Rhabdomyolysis Risk in Alzheimer’s Disease Patients Receiving Memantine: A Pharmacovigilance Study. Brac University, 2024.
MLA aipamenaTabassum, Nadira, and Hasina Yasmin. Gender-specific Rhabdomyolysis Risk in Alzheimer’s Disease Patients Receiving Memantine: A Pharmacovigilance Study. Brac University, 2024.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.